{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:23:16Z","timestamp":1700353396261},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Council of Rigshospitalet"},{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kidney transplant recipients receive maintenance immunosuppressive therapy to avoid allograft rejection resulting in increased risk of infections and infection-related morbidity and mortality. Approximately 98% of adults are infected with varicella zoster virus, which upon reactivation causes herpes zoster. The incidence of herpes zoster is higher in kidney transplant recipients than in immunocompetent individuals, and kidney transplant recipients are at increased risk of severe herpes zoster-associated disease. Vaccination with adjuvanted recombinant glycoprotein E subunit herpes zoster vaccine (RZV) prevents herpes zoster in older adults with excellent efficacy (90%), and vaccination of kidney transplant candidates is recommended in Danish and international guidelines. However, the robustness and duration of immune responses after RZV vaccination, as well as the optimal timing of vaccination in relation to transplantation remain unanswered questions. Thus, the aim of this study is to characterize the immune response to RZV vaccination in kidney transplant candidates and recipients at different timepoints before and after transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Herpes Virus Infections in Kidney Transplant Patients (HINT) study is a prospective observational cohort study. The study will include kidney transplant candidates on the waiting list for transplantation (<jats:italic>n<\/jats:italic>\u2009=\u2009375) and kidney transplant recipients transplanted since January 1, 2019 (<jats:italic>n<\/jats:italic>\u2009=\u2009500) from all Danish kidney transplant centers who are offered a RZV vaccine as routine care. Participants are followed with repeated blood sampling until 12\u00a0months after inclusion. In the case of transplantation or herpes zoster disease, additional blood samples will be collected until 12\u00a0months after transplantation. The immune response will be characterized by immunophenotyping and functional characterization of varicella zoster virus-specific T cells, by detection of anti-glycoprotein E antibodies, and by measuring cytokine profiles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The study will provide new knowledge on the immune response to RZV vaccination in kidney transplant candidates and recipients and the robustness and duration of the response, potentially enhancing preventive strategies against herpes zoster in a population at increased risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov (NCT05604911).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08663-5","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:02:21Z","timestamp":1697450541000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herpes Virus Infections in Kidney Transplant Patients (HINT) \u2013 a prospective observational cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Sebastian Rask","family":"Hamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemette","family":"Hald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Vaaben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasja Wulff","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises Alberto","family":"Suarez-Zdunek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zitta Barrella","family":"Harboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Bruunsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isik Somuncu","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten Schade","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Bistrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Birn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Schwartz","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sine Reker","family":"Hadrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"4","key":"8663_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","volume":"17","author":"JA Fishman","year":"2017","unstructured":"Fishman JA. Infection in Organ Transplantation. Am J Transplant. 2017;17(4):856\u201379. https:\/\/doi.org\/10.1111\/ajt.14208.","journal-title":"Am J Transplant"},{"key":"8663_CR2","unstructured":"Vaccine Scheduler | ECDC. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByCountry?SelectedCountryId=58&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=true&IncludeAdultAgeGroup=false. Accessed July 13, 2023."},{"issue":"11","key":"8663_CR3","doi-asserted-by":"publisher","first-page":"E3733","DOI":"10.1093\/CID\/CIAA824","volume":"73","author":"O Rezahosseini","year":"2021","unstructured":"Rezahosseini O, S\u00f8rensen SS, Perch M, et al. Measles, mumps, rubella, and varicella zoster virus serology and infections in solid organ transplant recipients during the first year posttransplantation. Clin Infect Dis. 2021;73(11):E3733\u20139. https:\/\/doi.org\/10.1093\/CID\/CIAA824.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8663_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/INFDIS\/JIU500","volume":"211","author":"D Schub","year":"2015","unstructured":"Schub D, Janssen E, Leyking S, et al. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. J Infect Dis. 2015;211(4):600\u201312. https:\/\/doi.org\/10.1093\/INFDIS\/JIU500.","journal-title":"J Infect Dis"},{"issue":"s3","key":"8663_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/AJT.12003","volume":"13","author":"RA Zuckerman","year":"2013","unstructured":"Zuckerman RA, Limaye AP. Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) in Solid Organ Transplant Patients. Am J Transplant. 2013;13(s3):55\u201366. https:\/\/doi.org\/10.1111\/AJT.12003.","journal-title":"Am J Transplant"},{"issue":"4","key":"8663_CR6","doi-asserted-by":"publisher","first-page":"e13674","DOI":"10.1111\/TID.13674","volume":"23","author":"DE Kwon","year":"2021","unstructured":"Kwon DE, Lee HS, Lee KH, La Y, Han SH, Song YG. Incidence of herpes zoster in adult solid organ transplant recipients: A meta-analysis and comprehensive review. Transpl Infect Dis. 2021;23(4):e13674. https:\/\/doi.org\/10.1111\/TID.13674.","journal-title":"Transpl Infect Dis"},{"key":"8663_CR7","doi-asserted-by":"publisher","unstructured":"Mckay SL, Guo A, Pergam SA, Dooling K. Herpes zoster risk in immunocompromised adults in the United States: A systematic review. https:\/\/doi.org\/10.1093\/cid\/ciz1090","DOI":"10.1093\/cid\/ciz1090"},{"issue":"6","key":"8663_CR8","doi-asserted-by":"publisher","first-page":"20528","DOI":"10.1136\/BMJOPEN-2017-020528","volume":"8","author":"EA Yanni","year":"2018","unstructured":"Yanni EA, Ferreira G, Guennec M, et al. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000\u20132012. BMJ Open. 2018;8(6):20528. https:\/\/doi.org\/10.1136\/BMJOPEN-2017-020528.","journal-title":"BMJ Open"},{"issue":"1","key":"8663_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/S12879-020-05648-6","volume":"20","author":"C Mu\u00f1oz-Quiles","year":"2020","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, D\u00edez-Domingo J, Orrico-S\u00e1nchez A. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009\u20132014. BMC Infect Dis. 2020;20(1):905. https:\/\/doi.org\/10.1186\/S12879-020-05648-6.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8663_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/S12879-015-1038-1","volume":"15","author":"ID Pavlopoulou","year":"2015","unstructured":"Pavlopoulou ID, Poulopoulou S, Melexopoulou C, Papazaharia I, Zavos G, Boletis IN. Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis. BMC Infect Dis. 2015;15(1):285. https:\/\/doi.org\/10.1186\/S12879-015-1038-1.","journal-title":"BMC Infect Dis"},{"key":"8663_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FIMMU.2021.645718","volume":"12","author":"MML Kho","year":"2021","unstructured":"Kho MML, Roest S, Bov\u00e9e DM, et al. Herpes zoster in solid organ transplantation: incidence and risk factors. Front Immunol. 2021;12:1. https:\/\/doi.org\/10.3389\/FIMMU.2021.645718.","journal-title":"Front Immunol"},{"issue":"11","key":"8663_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMOA1603800\/SUPPL_FILE\/NEJMOA1603800_DISCLOSURES.PDF","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019\u201332. https:\/\/doi.org\/10.1056\/NEJMOA1603800\/SUPPL_FILE\/NEJMOA1603800_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"issue":"22","key":"8663_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMOA1501184\/SUPPL_FILE\/NEJMOA1501184_DISCLOSURES.PDF","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396. https:\/\/doi.org\/10.1056\/NEJMOA1501184\/SUPPL_FILE\/NEJMOA1501184_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"issue":"2","key":"8663_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/JAMA.2019.9053","volume":"322","author":"A Bastidas","year":"2019","unstructured":"Bastidas A, De La Serna J, El Idrissi M, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA. 2019;322(2):123. https:\/\/doi.org\/10.1001\/JAMA.2019.9053.","journal-title":"JAMA"},{"issue":"2","key":"8663_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/CID\/CIZ177","volume":"70","author":"P Vink","year":"2020","unstructured":"Vink P, Torrell JMR, Fructuoso AS, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: A phase 3, randomized clinical trial. Clin Infect Dis. 2020;70(2):181. https:\/\/doi.org\/10.1093\/CID\/CIZ177.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8663_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/VACCINES10060844","volume":"10","author":"M Lindemann","year":"2022","unstructured":"Lindemann M, Baumann C, Wilde B, et al. Prospective, longitudinal study on specific cellular immune responses after vaccination with an adjuvanted, recombinant zoster vaccine in kidney transplant recipients. Vaccines (Basel). 2022;10(6):844. https:\/\/doi.org\/10.3390\/VACCINES10060844.","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"8663_CR17","doi-asserted-by":"publisher","first-page":"e13563","DOI":"10.1111\/ctr.13563","volume":"33","author":"L Danziger-Isakov","year":"2019","unstructured":"Danziger-Isakov L, Kumar D. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13563. https:\/\/doi.org\/10.1111\/ctr.13563.","journal-title":"Clin Transplant"},{"key":"8663_CR18","unstructured":"DSI guidelines \u00b7 DSI. https:\/\/www.infmed.dk\/guidelines. Accessed 10 July 2023."},{"issue":"1","key":"8663_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.VACCINE.2016.11.043","volume":"35","author":"MML Kho","year":"2017","unstructured":"Kho MML, Zuijderwijk JM, van der Eijk AA, et al. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates. Vaccine. 2017;35(1):71\u20136. https:\/\/doi.org\/10.1016\/J.VACCINE.2016.11.043.","journal-title":"Vaccine"},{"key":"8663_CR20","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/J.ANTIVIRAL.2020.104938","volume":"183","author":"C Rondaan","year":"2020","unstructured":"Rondaan C, de Joode AAE, Wang L, et al. Immune response to varicella-zoster virus before and after renal transplantation. Antiviral Res. 2020;183:104938. https:\/\/doi.org\/10.1016\/J.ANTIVIRAL.2020.104938.","journal-title":"Antiviral Res"},{"issue":"1","key":"8663_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/S12879-023-08153-8","volume":"23","author":"MA Suarez-Zdunek","year":"2023","unstructured":"Suarez-Zdunek MA, Saini SK, Pedersen CR, et al. Herpesvirus immunology in solid organ transplant recipients - liver transplant study (HISTORY): a retrospective and prospective observational cohort study. BMC Infect Dis. 2023;23(1):214. https:\/\/doi.org\/10.1186\/S12879-023-08153-8.","journal-title":"BMC Infect Dis"},{"issue":"9596","key":"8663_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"8663_CR23","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/J.JBI.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/J.JBI.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"Supplement_2","key":"8663_CR24","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1086\/522123","volume":"197","author":"AM Arvin","year":"2008","unstructured":"Arvin AM. Humoral and Cellular Immunity to Varicella-Zoster Virus: An Overview. J Infect Dis. 2008;197(Supplement_2):S58\u201360. https:\/\/doi.org\/10.1086\/522123.","journal-title":"J Infect Dis"},{"issue":"Database issue","key":"8663_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/NAR\/GKQ1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011;39(Database issue):913. https:\/\/doi.org\/10.1093\/NAR\/GKQ1128.","journal-title":"Nucleic Acids Res"},{"issue":"58","key":"8663_CR26","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.1126\/SCIIMMUNOL.ABF7550","volume":"6","author":"SK Saini","year":"2021","unstructured":"Saini SK, Hersby DS, Tamhane T, et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci Immunol. 2021;6(58):7550. https:\/\/doi.org\/10.1126\/SCIIMMUNOL.ABF7550.","journal-title":"Sci Immunol"},{"issue":"10","key":"8663_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/NBT.3662","volume":"34","author":"AK Bentzen","year":"2016","unstructured":"Bentzen AK, Marquard AM, Lyngaa R, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34(10):1037\u201345. https:\/\/doi.org\/10.1038\/NBT.3662.","journal-title":"Nat Biotechnol"},{"key":"8663_CR28","doi-asserted-by":"publisher","first-page":"e81810","DOI":"10.7554\/ELIFE.81810","volume":"12","author":"HR Povlsen","year":"2023","unstructured":"Povlsen HR, Bentzen AK, Kadivar M, Jessen LE, Hadrup SR, Nielsen M. Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cells. Elife. 2023;12:e81810. https:\/\/doi.org\/10.7554\/ELIFE.81810.","journal-title":"Elife"},{"issue":"17","key":"8663_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2807\/ESE.17.17.20155-EN","volume":"17","author":"T Grove Krause","year":"2012","unstructured":"Grove Krause T, Jakobsen S, Haarh M, M\u00f8lbak K. The Danish vaccination register. Euro Surveill. 2012;17(17):2. https:\/\/doi.org\/10.2807\/ESE.17.17.20155-EN.","journal-title":"Euro Surveill"},{"issue":"1","key":"8663_CR30","doi-asserted-by":"publisher","first-page":"20667","DOI":"10.2807\/1560-7917.ES2014.19.1.20667","volume":"19","author":"M Voldstedlund","year":"2014","unstructured":"Voldstedlund M, Haarh M, M\u00f8lbak K. The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014;19(1):20667. https:\/\/doi.org\/10.2807\/1560-7917.ES2014.19.1.20667.","journal-title":"Euro Surveill"},{"key":"8663_CR31","first-page":"V12220744","volume":"185","author":"K Sif","year":"2023","unstructured":"Sif K, Mosholt S, Rohrsted M, et al. Nyretransplantation i Danmark. Dan Med J. 2023;185:V12220744.","journal-title":"Dan Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08663-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:04:02Z","timestamp":1700319842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08663-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8663"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08663-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee of the Capital Region of Denmark (H-22042603) and the Knowledge Center for Data Reviews of the Capital Region of Denmark (P-2022\u2013953), and participants provide oral and written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SR. Hamm receives grants from the Research Council of Rigshospitalet related to this study. SDN has received unrestricted research grants from the Novo Nordisk Foundation, Lundbeck Foundation, the Independent Research Fund Denmark, and reports advisory board activity for Gilead Sciences and GlaxoSmithKline\/ViiV Healthcare, all unrelated to this manuscript. S.R. Hadrup is the cofounder of PokeAcell and coinventor of licensed patents related to T cell detection, but unrelated to this study. H. Birn has participated in advisory board activity for GlaxoSmithKline and has previously received research funding from GlaxoSmithKline unrelated to this study. SKS receives research funding from Lundbeck Foundation, the Danish Research Council, and the Danish Cancer Society for projects, all unrelated to this study. CSL has received honoraria from GlaxoSmithKline for lectures and participation in advisory boards. ZBH has received grants from Independent Research Fund, Lundbeck Foundation, Helen Rudes Foundation, and the Danish Cancer Society, all unrelated to this manuscript. ISJ, SSS, H. Bruunsgaard, AH, MASZ, CB, AVV, and NWP report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"687"}}